As COVID Recedes, New Challenges Arise
Key Points: In today’s Recommendations for Industry, we discuss how COVID-19 has impacted other areas of public health. Read more below. In the U.S., new
Key Points: In today’s Recommendations for Industry, we discuss how COVID-19 has impacted other areas of public health. Read more below. In the U.S., new
FDA Resumes Inspections, Plans 2022 Guidance FDA is back on the road and planning new focus areas for 2022. Two recent FDA announcements provided information